iShares US Pharmaceuticals ETF
IHE
IHE
120 hedge funds and large institutions have $122M invested in iShares US Pharmaceuticals ETF in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 37 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
Holders
120
Holding in Top 10
–
Calls
$412K
Puts
–
Top Buyers
| 1 | +$7.1M | |
| 2 | +$3.28M | |
| 3 | +$1.88M | |
| 4 |
Fisher Asset Management
Camas,
Washington
|
+$543K |
| 5 |
AWS
Atria Wealth Solutions
New York
|
+$372K |
Top Sellers
| 1 | -$3.1M | |
| 2 | -$2.7M | |
| 3 | -$2.35M | |
| 4 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
-$1.67M |
| 5 |
SPIA
Steward Partners Investment Advisory
New York
|
-$1.37M |